Kevin Gardner

Columbia University Irving Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index4.9kcitations248works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(40), BRCA gene mutations in cancer(28), Cancer-related gene regulation(27), Kruppel-like factors research(27), Nutrition, Genetics, and Disease(21)

Publications248 total

Topology-Based Biomarkers Accurately Predict Breast Cancer Outcome and Survival
Cancer Research·2026Open Access
Abstract C024: Somatic mutations in early-onset colorectal cancer: insights from a U.S. Hispanic cohort
Clinical Cancer Research·2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancer
Nature·2025· 2 citedOpen Access
Supplementary Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
2025Open Access
A novel spatial framework to validate arsenic exposure gene expression profiling in bladder cancer using multiplex FISH and AI-powered digital pathology
Scientific Reports·2025Open Access
Vibration therapy during needle procedures improves pain sensitivity while worsening pain threshold: A randomized, crossover study of healthy volunteers
The Journal of Vascular Access·2025
Association of Collapsing Glomerulopathy with Donor Apolipoprotein L1 Risk Variants in Kidney Allografts from Black Donors
Clinical Journal of the American Society of Nephrology·2025Open Access
Abstract 1736 Structural Insights of Homologous PhyR Interaction Complexes in a General Stress Response (GSR) Pathway
Journal of Biological Chemistry·2025Open Access
Abstract 2454: Spatial profiling of arsenic-responsive gene expression in bladder cancer models via multiplex in situ hybridization
Cancer Research·2025
New Spatial Phenotypes from Imaging Uncover Survival Differences for Breast Cancer Patients
2024· 1 citedOpen Access
Supplementary Data from Profiling the somatic mutational landscape of breast tumors from Hispanic/Latina women reveals conserved and unique characteristics
2024Open Access
Supplementary Data from Profiling the somatic mutational landscape of breast tumors from Hispanic/Latina women reveals conserved and unique characteristics
2024Open Access
LC3AB protein-based gene (PbG) signatures as an indicator of relapse even after achieving pathological complete response.
Journal of Clinical Oncology·2024
A set of molecular biomarkers as an indicator of cancer risk.
Journal of Clinical Oncology·2024· 2 cited
Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
2023Open Access
Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
2023Open Access
Supplementary Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
2023· 1 citedOpen Access
Supplementary Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
2023Open Access
NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer
2023· 7 citedOpen Access
Correlation of gene signatures of Kaiso and LC3A/B protein expression with distinct tumor ecosystems and to predict response to breast cancer therapy.
Journal of Clinical Oncology·2023
page 1 of 13Next →

Frequent Co-authors

Adriana De Siervi(14), Jung S. Byun(12), Paola De Luca(8), Cristian P. Moiola(7), Elba S. Vázquez(6), Cynthia M. Haggerty(6), Vann Bennett(5), Dan L. Longo(4), Florencia Zalazar(4), Guillermo Nicolás Dalton(4), Cintia Massillo(4), Madeline Wong(3), Clay Wakano(3), Lijun Di(3), Lisa A. Newman(3), Melissa B. Davis(3), Qingdi Li(3), Paula Lucía Farré(3), Anna María Nápoles(3), Michelle Olive(2)